Canada Biopsy Procedures Outlook to 2023
Summary
GlobalData’s new report, Canada Biopsy Procedures Outlook to 2023, provides key procedures data on the Canada Biopsy Procedures. The report provides procedure volumes within market segments - Breast Biopsy Procedures, Colorectal Biopsy Procedures, Leukemia Biopsy Procedures, Liver Biopsy Procedures, Lung Biopsy Procedures, Other Indications Biopsy Procedures, Prostate Biopsy Procedures and Thyroid Biopsy Procedures.
The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.
Scope
- Canada Biopsy Procedures volumes by segments - Breast Biopsy Procedures, Colorectal Biopsy Procedures, Leukemia Biopsy Procedures, Liver Biopsy Procedures, Lung Biopsy Procedures, Other Indications Biopsy Procedures, Prostate Biopsy Procedures and Thyroid Biopsy Procedures.
- Projections for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
Reasons to buy- Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Develop market-entry and market expansion strategies.
- 1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
- 2 Introduction
- 2.1 What Is This Report About?
- 2.2 Biopsy Procedures, Segmentation
- 2.3 Definitions of Procedures Covered in the Report
- 3 Biopsy Procedures, Canada
- 3.1 Biopsy Procedures, Canada, 2009-2016
- 3.2 Biopsy Procedures, Canada, 2016-2023
- 3.2.1 Breast Biopsy Procedures, Canada, 2009-2016
- 3.2.2 Colorectal Biopsy Procedures, Canada, 2009-2016
- 3.2.3 Leukemia Biopsy Procedures, Canada, 2009-2016
- 3.2.4 Liver Biopsy Procedures, Canada, 2009-2016
- 3.2.5 Lung Biopsy Procedures, Canada, 2009-2016
- 3.2.6 Other Indications Biopsy Procedures, Canada, 2009-2016
- 3.2.7 Prostate Biopsy Procedures, Canada, 2009-2016
- 3.2.8 Thyroid Biopsy Procedures, Canada, 2009-2016
- 3.2.9 Breast Biopsy Procedures, Canada, 2016-2023
- 3.2.10 Colorectal Biopsy Procedures, Canada, 2016-2023
- 3.2.11 Leukemia Biopsy Procedures, Canada, 2016-2023
- 3.2.12 Liver Biopsy Procedures, Canada, 2016-2023
- 3.2.13 Lung Biopsy Procedures, Canada, 2016-2023
- 3.2.14 Other Indications Biopsy Procedures, Canada, 2016-2023
- 3.2.15 Prostate Biopsy Procedures, Canada, 2016-2023
- 3.2.16 Thyroid Biopsy Procedures, Canada, 2016-2023
- 4 Appendix
- 4.1 Research Methodology
- 4.1.1 Coverage
- 4.1.2 Secondary Research
- 4.1.3 Primary Research
- 4.1.4 Market Modeling and Forecasting
- 4.1.5 Company Share Analysis
- 4.1.6 Distribution Share Analysis
- 4.1.7 Benchmarking
- 4.2 GlobalData Consulting
- 4.3 Contact Us
- 4.4 Disclaimer
- 1.1 List of Tables
- Table 1: Biopsy Procedures, Canada, Historic, 2009-2016
- Table 2: Biopsy Procedures, Canada, Forecast, 2016-2023
- Table 3: Breast Biopsy Procedures, Canada, Historic, 2009-2016
- Table 4: Colorectal Biopsy Procedures, Canada, Historic, 2009-2016
- Table 5: Leukemia Biopsy Procedures, Canada, Historic, 2009-2016
- Table 6: Liver Biopsy Procedures, Canada, Historic, 2009-2016
- Table 7: Lung Biopsy Procedures, Canada, Historic, 2009-2016
- Table 8: Other Indications Biopsy Procedures, Canada, Historic, 2009-2016
- Table 9: Prostate Biopsy Procedures, Canada, Historic, 2009-2016
- Table 10: Thyroid Biopsy Procedures, Canada, Historic, 2009-2016
- Table 11: Breast Biopsy Procedures, Canada, Forecast, 2016-2023
- Table 12: Colorectal Biopsy Procedures, Canada, Forecast, 2016-2023
- Table 13: Leukemia Biopsy Procedures, Canada, Forecast, 2016-2023
- Table 14: Liver Biopsy Procedures, Canada, Forecast, 2016-2023
- Table 15: Lung Biopsy Procedures, Canada, Forecast, 2016-2023
- Table 16: Other Indications Biopsy Procedures, Canada, Forecast, 2016-2023
- Table 17: Prostate Biopsy Procedures, Canada, Forecast, 2016-2023
- Table 18: Thyroid Biopsy Procedures, Canada, Forecast, 2016-2023
- Table 19: Total Number of Primary Research Participants, General Surgery Market, by Country
- 1.2 List of Figures
- Figure 1: Biopsy Procedures, Canada, Historic, 2009-2016
- Figure 2: Biopsy Procedures, Canada, Forecast, 2016-2023
- Figure 3: Breast Biopsy Procedures, Canada, Historic, 2009-2016
- Figure 4: Colorectal Biopsy Procedures, Canada, Historic, 2009-2016
- Figure 5: Leukemia Biopsy Procedures, Canada, Historic, 2009-2016
- Figure 6: Liver Biopsy Procedures, Canada, Historic, 2009-2016
- Figure 7: Lung Biopsy Procedures, Canada, Historic, 2009-2016
- Figure 8: Other Indications Biopsy Procedures, Canada, Historic, 2009-2016
- Figure 9: Prostate Biopsy Procedures, Canada, Historic, 2009-2016
- Figure 10: Thyroid Biopsy Procedures, Canada, Historic, 2009-2016
- Figure 11: Breast Biopsy Procedures, Canada, Forecast, 2016-2023
- Figure 12: Colorectal Biopsy Procedures, Canada, Forecast, 2016-2023
- Figure 13: Leukemia Biopsy Procedures, Canada, Forecast, 2016-2023
- Figure 14: Liver Biopsy Procedures, Canada, Forecast, 2016-2023
- Figure 15: Lung Biopsy Procedures, Canada, Forecast, 2016-2023
- Figure 16: Other Indications Biopsy Procedures, Canada, Forecast, 2016-2023
- Figure 17: Prostate Biopsy Procedures, Canada, Forecast, 2016-2023
- Figure 18: Thyroid Biopsy Procedures, Canada, Forecast, 2016-2023